Creation and Evaluation of a Mobile Intervention Team in Perinatal Psychiatry (0-3 Years) in Meurthe-et-Moselle Sud
Centre Psychothérapique de Nancy
4,260 participants
Aug 18, 2023
INTERVENTIONAL
Conditions
Summary
The research system is a Mobile Perinatal Psychiatry Team (EMPPer), for children aged 0 to 3 and their parents. it facilitates access to psychiatric care by going to families who need it and who are in difficulty to ensure this process. This device, already deployed in a dozen French cities for several years, convinced the teams of its interest, without demonstrating its effectiveness by evaluation conducted according to research standards. The deployment of a Mobile Perinatal Psychiatry Team in a region not yet equipped (Meurthe-et-Moselle Sud) would therefore offer the opportunity to assess its effectiveness, The main objective of the research is to evaluate the effect of the EMPPer on the prevalence of abnormalities in the psychomotor development of children at the age of 2 years, in comparison with similar territories that do not benefit from it, and in comparison with the period preceding the establishment of the EMPPer in the targeted territory.
Eligibility
Inclusion Criteria3
- Children benefiting from EMPPer intervention
- Children affiliated or entitled to a social security system
- Children for whom the holder of parental authority has received informed information about the study and has co-signed, with the investigator, a consent to participate in the study
Exclusion Criteria3
- Children whose parents are visiting the region ( vacations, family visits ...)
- Children for whom the 2 holders of parental authority do not speak french
- Children for whom both parents do not know how to read
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The Mobile Intervention Team in Perinatal Psychiatry consists in going towards the most excluded patients, changing the organization of care compared to the current practice and facilitating access to care for the most vulnerable populations
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05636878